Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2001 1
2007 1
2008 1
2009 1
2010 1
2014 2
2019 1
2022 1
2024 0

Text availability

Article attribute

Article type

Publication date

Search Results

9 results

Results by year

Filters applied: . Clear all
Page 1
MEK inhibitor sensitivity in BRAF fusion-driven prostate cancer.
Fenor MD, Ruiz-Llorente S, Rodríguez-Moreno JF, Caleiras E, Torrego JC, Sevillano-Fernández E, Navarro P, Yagüe-Fernández M, Amarilla-Quintana S, Barquín A, García-Donas J. Fenor MD, et al. Among authors: torrego jc. Clin Transl Oncol. 2022 Dec;24(12):2432-2440. doi: 10.1007/s12094-022-02916-6. Epub 2022 Aug 22. Clin Transl Oncol. 2022. PMID: 35994225
[The strange abscopal effect].
de la Cruz V, Sanz Á, Torrego JC, Bruno Fiorini A. de la Cruz V, et al. Among authors: torrego jc. Rev Clin Esp (Barc). 2014 Apr;214(3):170-1. doi: 10.1016/j.rce.2013.12.005. Epub 2014 Jan 16. Rev Clin Esp (Barc). 2014. PMID: 24439799 Spanish. No abstract available.
Preliminary safety and efficacy of first-line pertuzumab combined with trastuzumab and taxane therapy for HER2-positive locally recurrent or metastatic breast cancer (PERUSE).
Bachelot T, Ciruelos E, Schneeweiss A, Puglisi F, Peretz-Yablonski T, Bondarenko I, Paluch-Shimon S, Wardley A, Merot JL, du Toit Y, Easton V, Lindegger N, Miles D; PERUSE investigators. Bachelot T, et al. Ann Oncol. 2019 May 1;30(5):766-773. doi: 10.1093/annonc/mdz061. Ann Oncol. 2019. PMID: 30796821 Free article. Clinical Trial.
Sequential therapy in advanced non-small-cell lung cancer with weekly paclitaxel followed by cisplatin-gemcitabine-vinorelbine. A phase II study.
Feliu J, Martin G, Lizón J, Chacón JI, Dorta J, de Castro J, Rodríguez A, Sánchez Heras B, Torrego JC, Espinosa E, González Barón M; Oncopaz Cooperative Group, Spain. Feliu J, et al. Among authors: torrego jc. Ann Oncol. 2001 Oct;12(10):1369-74. doi: 10.1023/a:1012552525667. Ann Oncol. 2001. PMID: 11762806 Free article. Clinical Trial.
[Immunity against hepatitis A virus in patients with chronic hepatitis C].
Díez-Redondo MP, Almaraz A, Jiménez Rodríguez-Vila M, Santamaría A, de Castro J, Torrego JC, Caro-Patón A. Díez-Redondo MP, et al. Among authors: torrego jc. Med Clin (Barc). 2008 Oct 25;131(14):526-9. doi: 10.1157/13127577. Med Clin (Barc). 2008. PMID: 19080825 Spanish.
Heart metastases and superior vena cava syndrome.
Rubiales AS, Reyes A, Renedo AF, Torrego JC, Puertas J, Marcos G. Rubiales AS, et al. Among authors: torrego jc. Clin Transl Oncol. 2007 Aug;9(8):540-2. doi: 10.1007/s12094-007-0099-z. Clin Transl Oncol. 2007. PMID: 17720658
[Gastrointestinal metastasis from poorly differentiated neuroendocrine carcinoma].
Julián-Gómez L, Barrio J, Torrego JC, Gómez-de-la-Cuesta S, Ruiz L, Pérez-Miranda M, Caro-Patón A. Julián-Gómez L, et al. Among authors: torrego jc. Rev Esp Enferm Dig. 2010 Jul;102(8):512-4. doi: 10.4321/s1130-01082010000800015. Rev Esp Enferm Dig. 2010. PMID: 20670079 Free article. Spanish. No abstract available.